In an e-mail, a MM patient asked me where I was treated and if I would provide details. Well, sure.
I was treated at the University of Arkansas for Medical Sciences' Myeloma Institute for Research & Therapy (MIRT) in Little Rock, AR. http://myeloma.uams.edu/
The protocol that I followed was Total Therapy 4- Standard Arm. Dx- 11/25/08, IgG kappa, 77.5 % plasma cells at Dx (3% now!) , in Complete Remission. I'll share number progressions in later posts - when I'm convinced that people are actually reading this blog! : )
Total Therapy 4: Phase III Trial for Multiple Myeloma
11/24/08 Diagnosis IgG kappa
12/09/08 - Induction # 1
12/30/08 MVDTPACE
Stem Cell Collection - 24 Million
Velcade (days 1,5,8 and 11)
Melphalan (day 3)
DTPACE (days 5-8)
12/31/08 - Bridging
1/10/09 Dex / Thal
1/11/09 - Induction # 2
1/27/09 MVDTPACE
Velcade (days 1,4,8 and 11)
Melphalan (day 1)
DTPACE (days 1-4)
2/27/09 - Transplant # 1 (6 million stem cells)
3/17/09 Unfractionated Melphalan 200
Melphalan 200mg/m2 (day -1 )
Dexamethasone 40mg (days -2, -1, 0, and 1)
3/18/10- Bridging
4/12/10 Dex / Thal
(stop Thal. 7 days before Transplant)
4/13/09 Developed DVT
Hospitalized , Vena Cava Filter placed
Lovenox SQ prescribed for blood clots
5/13/09- Transplant # 2 (3 million stem cells)
5/29/09 Unfractionated Melphalan 200
Melphalan 200mg/m2 ( day -1 )(BSA Cap of 2.0)
Dexamethasone 40mg (days -2, -1, 0, and 1)
5/30/09- Bridging
7/13/09 Dex / Thal
7/14/09- Consolidation # 1
7/31/09 VDTPACE
Velcade (days 1,4,8 and 11)
DTPACE (days 1-4)
8/6/09 Kyphoplasty
(1) T-4
8/7/09- Bridging
9/3/09 Dex / Thal
9/4/09- Consolidation # 2
9/21/09 VDTPACE
Velcade (days 1,4,8 and 11)
DTPACE (days 1-4)
11/11/09- Maintenance
10/31/12 VRD (every 28 days x 3 years)
Velcade 1.9mg (days 1,8,15 and 22)
Dexamethasone 20mg (days 1,8,15 and 22)
Revlimid 15mg (days 1-21, off 22 – 28)
Zometa 4mg (every 3 months)
2/4/10 Kyphoplasty
(2) T 11-12
Drug Key:
V= Velcade
M= Melphalan
T = Thalidomide
D = Dexamethasone
P = Cisplatin
A = Adriamycin
C = Cyclophosphamide
E = Etoposide
G = Granulocyte Colony
Stimulating Factor
R = Revlimid,
What a year! All in all, I have fared well and feel pretty darn good. I still experience pain, neuropathy in my feet and hands, but I continue to progress. The treatment, as promised, was aggressively rough, but I'm still standing! Going to UAMS was a good decision for me.
graphic (c) UAMS/MIRT used with permission
1 comment:
I'm almost exactly a year behind you on TTY4-lite. So far my experiences mirror yours. I'm back at UAMS right now for Consolidation after the two transplants. As you know, the Lite arm has only one consolidation in this phase. For me, and for those that follow I sure hope that this turns out to be as effective as the "normal" TT3.
BTW, I had to set up a Google account. No big deal but I imagine it causes a number of people to decide not to communicate.
Post a Comment